Trending Topic

3d medical x ray of knee pain with arthritis inflammation and tendon injury, copy space
9 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The use of immune checkpoint inhibitors (ICIs) in treating cancer has greatly improved survival outcomes, particularly in patients with advanced disease for whom successful treatment options have previously been limited. For example, in patients with metastatic melanoma, the median survival time has improved from just 6 months to approximately 6 years with the use of […]

Michaela Koehm, ACR 2021: Methotrexate Effect on bDMARDs in the Treatment of Active PsA

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jan 17th 2022

We were delighted to speak with Dr. Michaela Koehm (Goethe University, Frankfurt am Main, Germany) to discuss her trial investigating the effect of methotrexate on ustekinumab treatment for active psoriatic arthritis.

This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.

The abstract ‘Neither Add-on nor Withdrawal of Methotrexate Impacts Efficacy of IL12/23 Inhibition in Active PsA: Data from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial on Arthritis, Dactylitis, Enthesitis, Psoriasis, QoL and Function.’ (ABSTRACT NUMBER: L12) was presented at the ACR Convergence, 5-9 November 2021.

  1. What is the rationale for combining methotrexate with a biological disease-modifying antirheumatic drug (DMARD) in the treatment of active psoriatic arthritis (PsA)? (0:20)
  2. What were the aims and design of the clinical trial you are presenting? (1:01)
  3. What were the efficacy and safety findings of the study? (1:40)
  4. Why do you think methotrexate had no effect on the efficacy of ustekinumab? (2:15)
  5. What questions remain unanswered and what future studies are planned? (4:04)

Disclosures: Michaela Koehm discloses receiving a research grant from Janssen.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Filmed in coverage of the virtual ACR Convergence 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup